Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
- PMID: 9296497
- DOI: 10.1038/38291
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
Abstract
Much of the predisposition to hereditary breast and ovarian cancer has been attributed to inherited defects in the BRCA1 tumour-suppressor gene. The nuclear protein BRCA1 has the properties of a transcription factor, and can interact with the recombination and repair protein RAD51. Young women with germline alterations in BRCA1 develop breast cancer at rates 100-fold higher than the general population, and BRCA1-null mice die before day 8 of development. However, the mechanisms of BRCA1-mediated growth regulation and tumour suppression remain unknown. Here we show that BRCA1 transactivates expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in a p53-independent manner, and that BRCA1 inhibits cell-cycle progression into the S-phase following its transfection into human cancer cells. BRCA1 does not inhibit S-phase progression in p21-/- cells, unlike p21+/+ cells, and tumour-associated, transactivation-deficient mutants of BRCA1 are defective in both transactivation of p21 and cell-cycle inhibition. These data suggest that one mechanism by which BRCA1 contributes to cell-cycle arrest and growth suppression is through the induction of p21.
Similar articles
-
The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.Oncogene. 1999 Jan 7;18(1):263-8. doi: 10.1038/sj.onc.1202323. Oncogene. 1999. PMID: 9926942
-
BRCA1 physically associates with p53 and stimulates its transcriptional activity.Oncogene. 1998 Apr 2;16(13):1713-21. doi: 10.1038/sj.onc.1201932. Oncogene. 1998. PMID: 9582019
-
The functions of the cdk-cyclin kinase inhibitor p21WAF1.Pathol Biol (Paris). 2000 Apr;48(3):190-202. Pathol Biol (Paris). 2000. PMID: 10858953 Review.
-
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.Int J Oncol. 2004 Mar;24(3):591-608. Int J Oncol. 2004. PMID: 14767544
-
[Cell cycle regulation after exposure to ionizing radiation].Bull Cancer. 1999 Apr;86(4):345-57. Bull Cancer. 1999. PMID: 10341340 Review. French.
Cited by
-
Classification of BRCA1 missense variants of unknown clinical significance.J Med Genet. 2005 Feb;42(2):138-46. doi: 10.1136/jmg.2004.024711. J Med Genet. 2005. PMID: 15689452 Free PMC article.
-
Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1.Breast Cancer (Auckl). 2014 Mar 23;8:51-6. doi: 10.4137/BCBCR.S14224. eCollection 2014. Breast Cancer (Auckl). 2014. PMID: 24678242 Free PMC article.
-
A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer.Int J Mol Sci. 2012 Nov 14;13(11):14898-916. doi: 10.3390/ijms131114898. Int J Mol Sci. 2012. PMID: 23203101 Free PMC article. Review.
-
Tumor suppressor p53 is required to modulate BRCA1 expression.Mol Cell Biol. 2000 Oct;20(20):7450-9. doi: 10.1128/MCB.20.20.7450-7459.2000. Mol Cell Biol. 2000. PMID: 11003642 Free PMC article.
-
Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2.Neoplasia. 2000 Sep-Oct;2(5):460-70. doi: 10.1038/sj.neo.7900104. Neoplasia. 2000. PMID: 11191113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous